Discover how two promising new experimental drugs targeting CGRP could help prevent migraines and significantly reduce monthly attacks.
Tag Archives: new drug
FDA approves Abstral (fentanyl) to help adult cancer patients manage breakthrough pain. Learn more about its uses, safety, and REMS program.
